8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001213900-19-025427
Bylaws or fiscal year change · Shareholder vote results
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading f8k120419_elitepharma.htm…